Physician
Rajjoub, Mohannad
Rajjoub, Mohannad was paid $1.14M by Medicaid between Jan 2018 and Jun 2023, across 45 billing codes. Its largest line is 0502F, — 24% of everything it billed.
33Billing provider infoRAJJOUB, MOHANNAD
MOORESVILLE, IN 46158
MOORESVILLE, IN 46158
33aNPI1255659587assigned 05/11/2010
33bProvider typeHospitalist Physician
28Total paid$1.14M
24GClaims24,453
24DCodes billed45
24AFirst – last monthJan 2018 – Jun 2023
Compared with peers
Next to other Hospitalist Physician providers in Indiana
Rank by total paid#2 of 35
Median peer was paid$10K
This provider vs. median112×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,330 | $201K | |
| 2019 | 5,682 | $246K | |
| 2020 | 4,313 | $190K | |
| 2021 | 4,497 | $240K | |
| 2022 | 4,064 | $240K | |
| 2023 | 567 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0502F | 24% | 6,418 | 3,022 | $277K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 23% | 3,991 | 2,143 | $262K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.8% | 1,399 | 1,175 | $89K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 7.5% | 1,401 | 753 | $85K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.0% | 1,904 | 1,628 | $80K |
| 76818 | 5.9% | 1,220 | 461 | $68K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 5.2% | 1,658 | 928 | $59K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 4.3% | 756 | 576 | $49K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 2.8% | 35 | 32 | $32K |
| 76801 | 2.1% | 352 | 255 | $24K | |
| 76830 | Ultrasound, transvaginal | 1.5% | 270 | 219 | $17K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.4% | 232 | 156 | $16K |
33 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 178 | $14K |
| 0500F | <1% | 243 | $11K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 185 | $10K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 92 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 597 | $6K |
| 59025 | Fetal non-stress test | <1% | 566 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 570 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 43 | $3K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 55 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 158 | $2K |
| 99219 | <1% | 32 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 42 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 58 | $2K |
| 90686 | <1% | 88 | $2K | |
| 84703 | <1% | 187 | $1K | |
| 87481 | <1% | 15 | $1K | |
| 90715 | <1% | 43 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 132 | $1K |
| 84439 | <1% | 139 | $1K | |
| 81001 | <1% | 356 | $994.01 | |
| 54150 | <1% | 12 | $930.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 17 | $870.20 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $824.40 |
| 86780 | <1% | 43 | $743.47 | |
| 87511 | <1% | 15 | $687.00 | |
| 82950 | <1% | 113 | $517.26 | |
| 82947 | <1% | 114 | $420.20 | |
| 86803 | <1% | 17 | $286.45 | |
| 81025 | <1% | 78 | $242.68 | |
| 87340 | <1% | 17 | $229.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 35 | $220.50 |
| 36415 | Collection of venous blood by venipuncture | <1% | 522 | $61.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.